Allergen-specific immunotherapy in the treatment of allergic diseases
- Authors: Varfolomeeva M.I.1, Kulagina I.T.1, Zaitsev A.A.1
-
Affiliations:
- The N.N.Burdenko Main Military Clinical Hospital of the Ministry of Defense of the Russian Federation
- Issue: Vol 344, No 6 (2023)
- Pages: 44-49
- Section: Treatment and prophylactic issues
- URL: https://journals.eco-vector.com/0026-9050/article/view/630157
- DOI: https://doi.org/10.52424/00269050_2023_344_6_44
- ID: 630157
Cite item
Open Access
Access granted
Subscription Access
Abstract
The role and necessity of allergen-specific immunotherapy in the treatment of allergic diseases such as allergic rhinitis, conjunctivitis, bronchial asthma, etc. is shown. A list of indications and contraindications for treatment is given. The key indication for allergen-specific immunotherapy is the presence of a proven IgE-dependent nature of the disease, as well as an established causal relationship between the allergens used and the allergic disease. The paper compares various methods of allergen-specific immunotherapy, considers its mechanism of action, safety and efficacy.
About the authors
M. I. Varfolomeeva
The N.N.Burdenko Main Military Clinical Hospital of the Ministry of Defense of the Russian Federation
Author for correspondence.
Email: mvarf@yandex.ru
кандидат медицинских наук
Russian Federation, MoscowI. T. Kulagina
The N.N.Burdenko Main Military Clinical Hospital of the Ministry of Defense of the Russian Federation
Email: mvarf@yandex.ru
кандидат медицинских наук
Russian Federation, MoscowA. A. Zaitsev
The N.N.Burdenko Main Military Clinical Hospital of the Ministry of Defense of the Russian Federation
Email: a-zaicev@yandex.ru
заслуженный врач РФ, профессор, полковник медицинской службы
Russian Federation, MoscowReferences
- Гущин И.С. Аллергическое воспаление и его фармакологический контроль. – М.: Фармарус принт., 1998. – 251 с.
- Гущин И.С., Курбачева О.М. Аллерген-специфическая иммунотерапия атопических заболеваний: Пособие для врачей. – М., 2002. – 32 с.
- Гущин И.С., Курбачева О.М. Аллергия и аллерген-специфическая иммунотерапия. – М.: Фармарус Принт Медиа, 2010. – 228 с.
- Курбачева О.М. Клинические, патогенетические и экономические аспекты применения аллерген-специфической иммунотерапии: Дис. ... д-ра мед. наук. – М., 2007. – 198 с.
- Курбачева О.М., Павлова К.С. Оценка клинической эффективности аллерген-специфической иммунотерапии при лечении больных атопическими респираторными заболеваниями // Физиол. и патол. иммунной системы. – 2005. – № 5. – С. 3–6.
- Курбачева О.М., Павлова К.С., Шульженко А.Е. Безопасность аллерген-специфической иммунотерапии // Пульмонология. – 2006. – № 2. – С. 38–43.
- Пичужкина О.В., Гущин И.С., Курбачева О.М. Реаранжировка иммунного ответа в результате проведения аллергенспецифической иммунотерапии // Иммунология. – 2013. – № 1. – С. 43–48.
- Akdis M., Akdis C.A. Mechanisms of allergen-specific immunotherapy // J. Allergy Clin. Immunol. – 2007. – Vol. 119. – P. 780–789.
- Akdis C.A., Akdis M. Mechanisms and treatment of allergic disease in the big picture of regulatory T cells // J. Allergy Clin. Immunol. – 2009. – Vol. 123. – P. 735–746.
- Akdis M., Schmidt-Weber C., Jutel M. et al. Mechanisms of allergen immunotherapy // Clin. Exp. Allergy. – 2004. – Vol. 4. – Р. 56–60.
- Bantz S.K., Zhu Z., Zheng T. The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma // J. Clin. Cell. Immunol. – 2014. – Vol. 5, Iss. 2. – P. 1–8
- Bousquet J., Lockey R., Malling H.J. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper // J. Allergy Clin. Immunol. – 1998. – Vol. 102, N 4 – P. 558–562.
- Calderon M.A., Alves B., Jacobson M. et al. Allergen injection immunotherapy for seasonal allergic rhinitis // Cochrane Database Syst. Rev. – 2007, Release 1.
- Deichmann K.A., Starke B., Schlenther S. et al. Linkage and association studies of atopy and the chromosome 11q13 region // J. med. genetics. – 1999. – Vol. 36, N 5 – P. 379–382.
- Jutel M., Agache I., Bonini S. et al. International consensus on allergy immunotherapy // J. Allergy Clin. Immunol. – 2015 – Vol. 136, N 3. – P. 556–568.
- Jutel M., Akdis C.A. Immunological mechanisms of allergen-specific immunotherapy // Allergy. – 2011. – Vol. 66, N 6. – P. 725–732.
- Khinchi M.S., Poulsen L.K., Carat F. et al. Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study // Allergy. – 2004. – Vol. 59. – P. 45–53.
- March M.E., Sleiman P.M., Hakonarson H. The genetics of asthma and allergic disorders // Discov. med. – 2011. – Vol. 11, N 56. – P. 35–45.
- Nelson H., Cartier S., Allen-Ramey F. et al. Network meta-analysis shows commercialized subcutaneous and sublingual grass products have comparable efficacy // J. Allergy Clin. Immunol. Pract. – 2015. – Vol. 3. – P. 256–266.
- Normansell R., Kew K.M., Bridgman A.L. Sublingual immunotherapy for asthma // Cochrane Database Syst. Rev. – 2015. – Vol. 28, Release 8.
- Ozdemir C. An immunological overview of allergen specific immunotherapy – subcutaneous and sublingual routes // Ther. Adv. Resp. dis. – 2009. – Vol. 3. – N 5. – P. 253–262.
- Ozdemir C., Akdis M., Akdis C.A. Nature of regulatory T cells in the context of allergic disease // Allergy Asthma Clin. Immunol. – 2008. – Vol. 15. – P. 106–110.
- Radulvic S., Calderon M.A., Wilson D., Durham S. Sublingual immunotherapy for allergic rhinitis // Cochrane database Syst. Rev. – 2010. – Vol. 8, Release 12.
Supplementary files
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).